ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7,501 | 72.81897 | 1 | male | 0 | 9 | 346 | CHF | COPD/CHF/Cirrhosis | 5 | 6 | under $11k | 0 | 6,878 | 4,825.4375 | 5,418.42969 | 10 | white | 17.898438 | 10 | 0.826904 | 0.717896 | 1 | 1 | 0 | yes | 1 | 0.6 | no dnr | 9 | 47 | 31.796875 | 158 | 28 | 36.59375 | 354.8125 | 3.299805 | 3.199707 | 3.899902 | 136 | 7.349609 | 165 | 62 | 2,534 | 0 | null | no(M2 and SIP pres) | 0.494751 |
7,502 | 63.94498 | 0 | male | 0 | 5 | 535 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | $11-$25k | 0 | 4,836 | 3,275.541 | 3,678.50977 | 12 | white | 16.398438 | 24 | 0.897949 | 0.827881 | 1 | 1 | 0 | no | 0.9 | 0.6 | no dnr | 5 | 141 | 8.898438 | 132 | 24 | 38.5 | 295.1875 | 3 | 0.699951 | 1.299805 | 137 | 7.529297 | 216 | 23 | 1,965 | 1 | 0 | SIP>=30 | 0 |
7,503 | 73.336 | 1 | female | 0 | 7 | 100 | COPD | COPD/CHF/Cirrhosis | 4 | null | under $11k | 0 | 10,886 | 6,786.2812 | 7,725.66797 | 11 | black | 29.597656 | 39 | 0.584961 | 0.391968 | 1 | 0 | 0 | yes | 0.5 | 0.5 | no dnr | 7 | 114 | 19 | 111 | 40 | 35.79688 | 190 | 3 | 0.699951 | 2.799805 | 144 | 7.40918 | 204 | 50 | 910 | null | 0 | adl>=4 (>=5 if sur) | 0 |
7,504 | 61.72198 | 1 | male | 0 | 4 | 93 | COPD | COPD/CHF/Cirrhosis | 3 | 10 | under $11k | 0 | 5,234 | 3,014.6914 | 3,693.28906 | 16 | white | 13.699219 | 18 | 0.924927 | 0.872925 | 1 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 4 | 122 | 17.796875 | 120 | 36 | 38.39844 | 134 | 2.5 | 0.5 | 0.299988 | 145 | 7.379883 | 74 | 14 | 1,979 | 0 | null | no(M2 and SIP pres) | 0.494751 |
7,505 | 68.07098 | 0 | male | 0 | 15 | 531 | Cirrhosis | COPD/CHF/Cirrhosis | 6 | 9 | under $11k | 0 | 47,397 | 31,747.0938 | 40,763.0312 | 41.333313 | white | 20.097656 | 35 | 0.738892 | 0.590942 | 1 | 0 | 0 | no | 0.3 | 0.1 | no dnr | 15 | 126 | 11.298828 | 120 | 32 | 38.89844 | 167.5 | 2.299805 | 4.599609 | 0.699951 | 142 | 7.519531 | 96 | 17 | 1,045 | null | 2 | adl>=4 (>=5 if sur) | 2 |
7,506 | 64.99896 | 0 | male | 0 | 15 | 531 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 11 | under $11k | 0 | 40,531 | 25,163.0469 | 28,500.7656 | 28 | white | 30.796875 | 60 | 0.689941 | 0.5979 | 1 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 15 | 123 | 15.398438 | 59 | 6 | 36.19531 | 293.3125 | 4.299805 | 0.599976 | 1.5 | 146 | 7.439453 | 202 | 24 | 4,240 | null | 1 | no(M2 and SIP pres) | 1 |
7,507 | 57.96298 | 1 | male | 1 | 13 | 13 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 12 | $11-$25k | 100 | 50,618 | 31,324.4531 | 37,703.9062 | 52.5 | white | 37.5 | 67 | 0.021 | 0.001 | 1 | 0 | 0 | no | 0.2 | 0.1 | dnr after sadm | 13 | 69 | 13.699219 | 107 | 28 | 37.5 | 185.6875 | 2.799805 | 0.399963 | 1.5 | 130 | 7.429688 | 119 | 26 | 7.5 | null | 2 | <2 mo. follow-up | 2 |
7,508 | 53.82599 | 0 | female | 0 | 10 | 530 | COPD | COPD/CHF/Cirrhosis | 0 | 10 | $11-$25k | 0 | 21,187 | 12,924.2812 | 14,137.7656 | 29.5 | white | 22.296875 | 39 | 0.887939 | 0.81189 | 1 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 10 | 125 | 23.898438 | 107 | 34 | 36 | 260 | 3 | 1 | 0.699951 | 134 | 7.509766 | 156 | 16 | 1,685 | 0 | 4 | null | 4 |
7,509 | 26.91299 | 0 | male | 0 | 15 | 529 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 10 | $25-$50k | 0 | 20,458 | 13,595.0078 | 15,301.2656 | 12.333328 | white | 21.5 | 31 | 0.919922 | 0.889893 | 1 | 0 | 0 | no | 0.8 | 0.89 | no dnr | 15 | 79 | 3.5 | 76 | 20 | 36.5 | null | 3 | 5.299805 | 1.099854 | 130 | null | 97 | 7 | 3,050 | null | 5 | adl>=4 (>=5 if sur) | 5 |
7,510 | 57.79599 | 0 | male | 0 | 40 | 528 | ARF/MOSF w/Sepsis | ARF/MOSF | 5 | 11 | under $11k | 100 | 114,737 | 75,503.9375 | 87,248 | 44.25 | white | 75.5 | 92 | 0 | 0 | 3 | 1 | 0 | no | 0.3 | 0.1 | no dnr | 40 | 111 | 13.298828 | 103 | 22 | 36 | 386 | 2.299805 | 0.599976 | 1.199951 | 133 | 7.469727 | 71 | 18 | 2,295 | null | 6 | SIP>=30 | 6 |
7,511 | 65.94397 | 0 | female | 0 | 27 | 527 | Coma | Coma | 0 | 12 | $11-$25k | 94 | 86,330 | 55,693.9688 | 65,210.0938 | 32 | white | 24.597656 | 36 | 0.128998 | 0.081985 | 9 | 0 | 0 | no | 0.75 | 0.85 | no dnr | 27 | 67 | 11.898438 | 157 | 36 | 38.69531 | 97.5 | 1.799805 | 0.5 | 0.599976 | 133 | 7.529297 | 198 | 10 | 3,160 | null | 0 | adl>=4 (>=5 if sur) | 0 |
7,512 | 71.35394 | 1 | male | 0 | 8 | 350 | Colon Cancer | Cancer | 3 | 12 | $11-$25k | 0 | 5,664 | 4,086.1523 | 5,531.9375 | 7.5 | white | 16.296875 | 14 | 0.814941 | 0.601929 | 1 | 1 | 0 | metastatic | 0.1 | 0 | no dnr | 8 | 118 | 8.5 | 120 | 28 | 37.69531 | 306.625 | 2.5 | 14.699219 | 0.699951 | 145 | 7.489258 | 74 | 10 | 4,655 | 0 | 1 | no(M2 and SIP pres) | 1 |
7,513 | 39.15399 | 0 | female | 0 | 21 | 526 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | under $11k | 0 | 65,108 | 41,013.4688 | 47,491.8125 | 34 | white | 21.097656 | 16 | 0.902954 | 0.86792 | 1 | 0 | 0 | no | 0.7 | 0.7 | no dnr | 21 | 49 | 5.299805 | 68 | 20 | 35 | null | 3.199707 | 0.5 | 1.299805 | 143 | null | 159 | 58 | 1,220 | null | 7 | null | 7 |
7,514 | 63.211 | 1 | male | 1 | 12 | 12 | Lung Cancer | Cancer | 2 | null | under $11k | 0 | 13,598 | 9,065.5 | 12,148.6797 | 14.5 | black | 30.199219 | 37 | 0.371948 | 0.08699 | 1 | 0 | 0 | metastatic | 0.3 | 0.1 | dnr after sadm | 10 | 115 | 8.699219 | 80 | 28 | 36.39844 | 186.9375 | 4 | 1.799805 | 1.199951 | 139 | 7.40918 | 170 | 32 | 3,030 | null | 0 | <2 mo. follow-up | 0 |
7,515 | 58.53 | 1 | male | 0 | 3 | 155 | Lung Cancer | Cancer | 1 | 13 | $11-$25k | 0 | 4,163 | 0 | 0 | null | black | 18.597656 | 31 | 0.691895 | 0.401978 | 1 | 0 | 0 | metastatic | 1 | 1 | no dnr | 3 | 115 | 14.699219 | 67 | 42 | 39.39844 | 142 | 3.099609 | 7.599609 | 0.699951 | 142 | 7.429688 | 96 | 11 | 4,586 | null | null | no(M2 and SIP pres) | 2.467285 |
7,516 | 41.97098 | 1 | female | 1 | 7 | 7 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 16 | >$50k | 0 | 28,025 | 17,503.9375 | 21,088.6406 | 47.5 | white | 23.296875 | 46 | 0.856934 | 0.807983 | 4 | 0 | 0 | no | 0.37 | 0.23 | no dnr | 7 | 87 | 7.299805 | 72 | 24 | 37.59375 | null | null | null | 0.899902 | 136 | null | 211 | 17 | null | null | 0 | <2 mo. follow-up | 0 |
7,517 | 42.31097 | 1 | male | 1 | 8 | 8 | MOSF w/Malig | ARF/MOSF | 1 | 16 | under $11k | 0 | 11,722 | 7,771.1914 | 9,862.02344 | 20.5 | white | 31.796875 | 53 | 0.419983 | 0.300964 | 3 | 0 | 0 | metastatic | 0 | 0 | dnr after sadm | 3 | 118 | 22 | 113 | 25 | 35.5 | 165 | 3.099609 | 1.199951 | 11.699219 | 141 | 7.389648 | 145 | 111 | 4 | 0 | 2 | <2 mo. follow-up | 2 |
7,518 | 72.60498 | 1 | female | 0 | 3 | 29 | Lung Cancer | Cancer | 3 | 8 | under $11k | 0 | 1,733 | 1,235.1172 | 1,652.92969 | null | white | 31.699219 | 17 | 0.294983 | 0.047997 | 1 | 1 | 0 | metastatic | 0.1 | 0 | dnr before sadm | -1 | 99 | 4.699219 | 76 | 20 | 37.89844 | null | 4.699219 | 1 | 0.899902 | 141 | null | 97 | 14 | null | null | null | <2 mo. follow-up | 3.372559 |
7,519 | 48.27399 | 1 | female | 1 | 45 | 45 | Coma | Coma | 0 | 10 | $25-$50k | 94 | 91,330 | 60,467.9062 | 69,929.5 | 44 | white | 24.5 | 49 | 0.390991 | 0.316956 | 1 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 31 | 60 | 12.699219 | 64 | 30 | 38.5 | 134 | 2.699707 | 0.799927 | 0.599976 | 140 | 7.5 | 104 | 5 | 2,444 | null | 0 | <2 mo. follow-up | 0 |
7,520 | 65.40698 | 0 | female | 0 | 32 | 518 | Coma | Coma | 1 | 12 | under $11k | 44 | 75,896 | 51,033.0938 | 59,645.875 | 29 | white | 18.898438 | 9 | 0.523926 | 0.452942 | 14 | 0 | 1 | no | 0.65 | 0.65 | no dnr | 32 | 77 | 10 | 68 | 28 | 36.39844 | null | null | 1 | 1.199951 | 136 | null | 369 | 26 | null | null | 4 | adl>=4 (>=5 if sur) | 4 |
7,521 | 54.31097 | 0 | female | 0 | 4 | 517 | CHF | COPD/CHF/Cirrhosis | 6 | 8 | $11-$25k | 0 | 4,114 | 2,559.4043 | 3,203.91992 | 15 | white | 23 | 20 | 0.860962 | 0.769897 | 1 | 1 | 0 | no | 0.5 | 0.4 | no dnr | 4 | 144 | 13.398438 | 65 | 36 | 39.19531 | 178 | 3.299805 | 0.899902 | 1.599854 | 133 | 7.469727 | 184 | 16 | 2,137 | 2 | null | SIP>=30 | 1.838867 |
7,522 | 61.03198 | 0 | female | 0 | 3 | 516 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | $11-$25k | 0 | 4,608 | 2,287.1426 | 2,884.43945 | null | white | 15.398438 | 16 | 0.886963 | 0.81189 | 1 | 0 | 0 | yes | 0.4 | 0.3 | no dnr | 3 | 121 | 19.597656 | 144 | 48 | 38.39844 | 197.9375 | 2.799805 | 0.799927 | 2.799805 | 142 | 7.419922 | 170 | 39 | 2,525 | null | null | no(M2 and SIP pres) | 2.261231 |
7,523 | 45.55499 | 1 | male | 0 | 9 | 320 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 11 | under $11k | 0 | 16,900 | 10,686.7422 | 12,602.9297 | 29 | white | 27.597656 | 47 | 0.754883 | 0.611938 | 1 | 0 | 0 | no | 0.85 | 0.75 | no dnr | 9 | 113 | 7.099609 | 96 | 24 | 35.29688 | null | 2.899902 | 0.599976 | 2.299805 | 137 | null | 66 | 35 | 3,550 | 0 | null | null | 0.494751 |
7,524 | 76.41595 | 0 | male | 0 | 6 | 513 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 17,222 | 9,349.5156 | 11,712.0156 | 27 | hispanic | 19.699219 | 6 | 0.787964 | 0.660889 | 1 | 0 | 0 | yes | 0.95 | 0.9 | no dnr | 6 | 66 | 9.5 | 78 | 26 | 36 | 212.875 | 3.099609 | 0.899902 | 1.399902 | 131 | 7.40918 | 137 | 33 | 2,581 | 1 | 0 | SIP>=30 | 0 |
7,525 | 55.73999 | 1 | male | 0 | 5 | 46 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | under $11k | 0 | 4,888 | 3,340.1641 | 3,512.76953 | 7 | white | 27.296875 | 36 | 0.802979 | 0.682983 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 5 | 81 | 5.399414 | 68 | 18 | 37 | null | 3.199707 | 0.399963 | 4.299805 | 141 | null | 81 | 60 | null | 0 | null | <2 mo. follow-up | 0.494751 |
7,526 | 49.008 | 0 | female | 0 | 4 | 509 | CHF | COPD/CHF/Cirrhosis | 4 | 16 | under $11k | 0 | 3,640 | 2,666.0059 | 2,941.5293 | 11 | black | 10.898438 | 19 | 0.950928 | 0.916992 | 1 | 0 | 0 | no | 0.7 | 0.5 | no dnr | 4 | 109 | 10.898438 | 111 | 40 | 37.69531 | 142.5 | null | null | 0.899902 | 135 | 7.389648 | 131 | 6 | 883 | 1 | null | SIP>=30 | 1.166748 |
7,527 | 31.55399 | 0 | female | 0 | 22 | 507 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | $11-$25k | 0 | 38,997 | 25,602.6406 | 28,688.6094 | 19.333328 | hispanic | 30.5 | 37 | 0.827881 | 0.768921 | 1 | 1 | 0 | no | 0.9 | 0.9 | no dnr | 22 | 63 | 200 | 156 | 32 | 39.09375 | null | 3.199707 | 0.899902 | 1.199951 | 140 | null | 101 | 9 | 4,600 | 2 | 0 | SIP>=30 | 0 |
7,528 | 56.616 | 0 | male | 0 | 12 | 507 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 18 | $25-$50k | 0 | 19,741 | 12,691.1953 | 14,891.0391 | 24.5 | white | 17.796875 | 26 | 0.837891 | 0.734985 | 1 | 0 | 0 | no | 0.75 | 0.65 | no dnr | 12 | 157 | 17.796875 | 179 | 41 | 39.59375 | 215 | 3.399902 | 0.699951 | 1.299805 | 133 | 7.519531 | 315 | 18 | 1,264 | 1 | 1 | null | 1 |
7,529 | 66.78699 | 0 | female | 0 | 13 | 507 | MOSF w/Malig | ARF/MOSF | 1 | 10 | under $11k | 9 | 26,886 | 18,592.5 | 22,514.9531 | 17.5 | black | 28.398438 | 52 | 0.367981 | 0.25 | 10 | 0 | 0 | metastatic | 0.5 | 0.4 | dnr before sadm | -4 | 105 | 11.099609 | 60 | 20 | 38.29688 | null | 3.399902 | 0.5 | 1.599854 | 137 | null | 463 | 29 | null | null | 7 | null | 7 |
7,530 | 74.13599 | 0 | female | 0 | 44 | 507 | COPD | COPD/CHF/Cirrhosis | 6 | 4 | under $11k | 9 | 71,806 | 47,299.75 | 51,366.7812 | 23.25 | black | 27.597656 | 52 | 0.655884 | 0.478943 | 1 | 1 | 0 | no | 0.95 | 0.9 | no dnr | 44 | 121 | 19.796875 | 63 | 64 | 35.5 | 288 | 2.399902 | 1.699951 | 0.799927 | 141 | 7.469727 | 257 | 12 | 5,725 | 5 | 0 | adl>=4 (>=5 if sur) | 0 |
7,531 | 30.39 | 1 | male | 0 | 6 | 26 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | 11 | under $11k | 0 | 6,106 | 4,069.7422 | 5,218.54688 | 10 | white | 28.796875 | 35 | 0.821899 | 0.709961 | 1 | 0 | 0 | no | 1 | 0.9 | no dnr | 6 | 85 | 8.599609 | 92 | 20 | 37.39844 | null | 2.399902 | 1.599854 | 0.899902 | 132 | null | 100 | 12 | null | 1 | 0 | <2 mo. follow-up | 0 |
7,532 | 26.35999 | 0 | female | 0 | 48 | 506 | COPD | COPD/CHF/Cirrhosis | 4 | 11 | under $11k | 0 | 95,201 | 59,971.8125 | 67,958.5 | 25.25 | black | 19.796875 | 19 | 0.962891 | 0.93689 | 1 | 0 | 0 | no | 0.85 | 0.7 | no dnr | 48 | 97 | 4.799805 | 100 | 28 | 36.79688 | 91.42188 | 3.699707 | 0.599976 | 0.799927 | 134 | 7.369141 | 162 | 10 | 2,100 | null | 4 | SIP>=30 | 4 |
7,533 | 43.03897 | 1 | female | 0 | 7 | 227 | MOSF w/Malig | ARF/MOSF | 2 | 10 | under $11k | 37 | 48,817 | 31,306.2031 | 35,121.6875 | 19.5 | black | 25.398438 | 45 | 0.426941 | 0.306946 | 19 | 0 | 0 | yes | 0.55 | 0.5 | no dnr | 7 | 101 | 6.799805 | 96 | 16 | 36 | null | 3.099609 | 0.799927 | 1.099854 | 135 | null | 80 | 27 | 2,050 | null | 0 | no(M2 and SIP pres) | 0 |
7,534 | 79.02496 | 1 | female | 0 | 5 | 83 | Lung Cancer | Cancer | 2 | 12 | under $11k | 9 | 5,753 | 3,172.6074 | 3,622.81836 | 8 | white | 24.796875 | 19 | 0.427979 | 0.121994 | 1 | 0 | 0 | metastatic | 0.35 | 0.05 | dnr after sadm | 2 | 71 | 18.398438 | 80 | 20 | 36 | 308.6875 | null | null | 1.199951 | 140 | 7.439453 | 108 | 23 | null | 5 | 5 | SIP>=30 | 5 |
7,535 | 23.11299 | 0 | male | 0 | 43 | 503 | Coma | Coma | 0 | 12 | under $11k | 61 | 104,075 | 66,718.4375 | 77,519.875 | 35.5 | black | 23.5 | 35 | 0.740967 | 0.692993 | 3 | 0 | 0 | no | 0.05 | 0.02 | no dnr | 43 | 107 | 11.798828 | 76 | 24 | 37.89844 | null | 3.599609 | 0.5 | 3.099609 | 135 | null | 104 | 33 | 5,300 | null | 0 | adl>=4 (>=5 if sur) | 0 |
7,536 | 44.42999 | 0 | male | 0 | 5 | 503 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | $25-$50k | 0 | 3,720 | 2,596.6738 | 2,879.49805 | 13 | black | 17.398438 | 9 | 0.92688 | 0.875977 | 1 | 1 | 0 | no | 0.99 | 0.9 | no dnr | 5 | 113 | 7.299805 | 104 | 24 | 39.59375 | null | 2.899902 | 0.5 | 0.799927 | 134 | null | 379 | 4 | 3,700 | 0 | 0 | no(M2 and SIP pres) | 0 |
7,537 | 64.12 | 0 | male | 0 | 18 | 503 | CHF | COPD/CHF/Cirrhosis | 7 | 12 | $11-$25k | 0 | 40,679 | 21,071.2031 | 25,232.2188 | 20.666656 | white | 35.398438 | 73 | 0.545898 | 0.347961 | 4 | 1 | 0 | no | 0.05 | 0.01 | dnr after sadm | 14 | 125 | 3.899902 | 72 | 22 | 36.29688 | 309.5 | null | null | 1.199951 | 146 | 7.429688 | 108 | 27 | 2,075 | 0 | 1 | no(M2 and SIP pres) | 1 |
7,538 | 54.19299 | 1 | male | 0 | 10 | 55 | COPD | COPD/CHF/Cirrhosis | 3 | 11 | under $11k | 0 | 12,546 | 7,809.6836 | 8,627.97656 | 13 | white | 16.097656 | 13 | 0.929932 | 0.880981 | 1 | 0 | 0 | no | 0.95 | 0.9 | no dnr | 10 | 80 | 4.899414 | 50 | 22 | 36.19531 | null | 3.599609 | 0.899902 | 1.5 | 152 | null | 94 | 16 | 1,695 | 3 | 4 | <2 mo. follow-up | 4 |
7,539 | 18.77599 | 0 | male | 0 | 12 | 501 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | $25-$50k | 0 | 31,368 | 19,824.9375 | 22,587.9688 | 41.5 | white | 29.898438 | 33 | 0.86792 | 0.821899 | 1 | 0 | 0 | no | 0.65 | 0.6 | no dnr | 12 | 94 | 17.097656 | 100 | 32 | 37.89844 | 46.66406 | 3.399902 | 1.099854 | 1.699951 | 142 | 7.549805 | 125 | 42 | 795 | 0 | 0 | no(M2 and SIP pres) | 0 |
7,540 | 72.97998 | 0 | female | 0 | 10 | 501 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 8 | under $11k | 9 | 13,111 | 7,897.5391 | 8,604.72656 | 16.5 | white | 18.597656 | 25 | 0.831909 | 0.775879 | 1 | 1 | 0 | no | 0.5 | 0.2 | dnr after sadm | 3 | 81 | 8.5 | 58 | 20 | 36.19531 | null | 4.199219 | 1 | 1.199951 | 137 | null | 84 | 12 | null | null | 1 | adl>=4 (>=5 if sur) | 1 |
7,541 | 70.43695 | 1 | female | 1 | 7 | 7 | Coma | Coma | 3 | null | under $11k | 44 | 30,399 | 19,896.4531 | 22,794.8281 | 25.5 | black | 33.195313 | 73 | 0.093994 | 0.056 | 13 | 1 | 0 | no | 0.1 | 0.05 | dnr after sadm | 1 | 109 | 6.5 | 74 | 20 | 36.09375 | null | 3.099609 | 6.599609 | 1 | 134 | null | 109 | 11 | null | null | 6 | <2 mo. follow-up | 6 |
7,542 | 67.86597 | 1 | male | 1 | 32 | 32 | CHF | COPD/CHF/Cirrhosis | 4 | 8 | under $11k | 37 | 61,337 | 39,699.4375 | 44,266.5938 | 20.25 | white | 18.199219 | 37 | 0.776978 | 0.643921 | 2 | 1 | 0 | no | 0.8 | 0.8 | no dnr | 32 | 153 | 4.699219 | 54 | 38 | 37.89844 | 319 | 3.199707 | 0.5 | 0.899902 | 142 | 7.459961 | 107 | 7 | 3,154 | null | 0 | <2 mo. follow-up | 0 |
7,543 | 25.54099 | 0 | male | 0 | 9 | 498 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 14 | under $11k | 0 | 14,621 | 9,416.0859 | 10,230.5234 | 17 | asian | 28.398438 | 29 | 0.866943 | 0.820923 | 1 | 0 | 0 | no | 0.95 | 0.95 | no dnr | 9 | 121 | 20 | 60 | 24 | 36.69531 | 392 | 2.899902 | 0.399963 | 3.899902 | 137 | 7.399414 | 376 | 57 | null | 0 | null | null | 0.494751 |
7,544 | 67.61896 | 1 | male | 0 | 41 | 58 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 16 | $25-$50k | 0 | 114,873 | 74,604.5625 | 85,581.0625 | 37 | white | 26 | 43 | 0.559937 | 0.447998 | 12 | 0 | 0 | metastatic | 0.4 | 0.3 | no dnr | 41 | 69 | 2.399902 | 66 | 20 | 34.5 | 280.9375 | 3.299805 | 0.799927 | 0.799927 | 141 | 7.55957 | 166 | 11 | null | null | 0 | <2 mo. follow-up | 0 |
7,545 | 44.09299 | 0 | male | 0 | 5 | 496 | Lung Cancer | Cancer | 3 | 12 | under $11k | 0 | 3,904 | 2,738.0293 | 3,507.14844 | 13 | black | 11.5 | 11 | 0.834961 | 0.638916 | 1 | 0 | 0 | metastatic | 0.75 | 0.6 | no dnr | 5 | 124 | 6.399414 | 146 | 36 | 35.69531 | 261.875 | 2.299805 | 2.799805 | 6.899414 | 143 | 7.209961 | 54 | 40 | 2,036 | 0 | null | no(M2 and SIP pres) | 0.494751 |
7,546 | 33.741 | 0 | male | 0 | 28 | 494 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 10 | under $11k | 0 | 88,800 | 58,121.7188 | 72,872.375 | 43.5 | white | 30.796875 | 47 | 0.779907 | 0.708984 | 5 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 28 | 119 | 14.599609 | 131 | 33 | 40.09375 | 131.09375 | null | null | 1.599854 | 151 | 7.479492 | 180 | 26 | 2,735 | null | 0 | no(M2 and SIP pres) | 0 |
7,547 | 49.09 | 0 | female | 0 | 8 | 493 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 14 | under $11k | 0 | 10,245 | 6,872.3477 | 7,327.44922 | 9 | white | 35.195313 | 22 | 0.67688 | 0.581909 | 1 | 0 | 0 | no | 0.9 | 0.75 | no dnr | 8 | 76 | 33.195313 | 124 | 10 | 38.79688 | 86.65625 | 1.899902 | 4.399414 | 1 | 143 | 7.459961 | 89 | 17 | 4,050 | 0 | null | no(M2 and SIP pres) | 0.494751 |
7,548 | 63.88797 | 0 | male | 0 | 75 | 492 | COPD | COPD/CHF/Cirrhosis | 4 | null | under $11k | 0 | 187,289 | 113,972.438 | 129,011.125 | 30.75 | white | 20.199219 | 30 | 0.844971 | 0.744995 | 4 | 0 | 0 | no | 0.85 | 0.8 | no dnr | 75 | 100 | 4.799805 | 72 | 16 | 36.09375 | 504.75 | 5.199219 | 5.299805 | 1.099854 | 135 | 7.439453 | 155 | 13 | 4,150 | null | 0 | adl>=4 (>=5 if sur) | 0 |
7,549 | 73.88599 | 1 | female | 1 | 12 | 12 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | null | 0 | 81,752 | 51,140.0625 | 62,188 | 64.5 | white | 39.195313 | 80 | 0.344971 | 0.228973 | 5 | 0 | 0 | no | 0 | 0 | dnr after sadm | 12 | 167 | 8.898438 | 122 | 10 | 38.09375 | 200 | 1.5 | 8.599609 | 0.799927 | 137 | 7.189453 | 197 | 27 | 1,548 | null | 1 | <2 mo. follow-up | 1 |
7,550 | 32.65198 | 0 | male | 0 | 18 | 491 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | under $11k | 0 | 23,825 | 15,030.7344 | 16,773.9375 | 19.333328 | white | 27.199219 | 29 | 0.861938 | 0.813965 | 1 | 0 | 0 | no | 0.85 | 0.8 | no dnr | 18 | 155 | 10.699219 | 72 | 32 | 39.19531 | 370 | 3.199707 | 0.899902 | 3 | 142 | 7.40918 | 126 | 32 | 1,715 | 4 | null | no(M2 and SIP pres) | 3.183106 |
7,551 | 92.65399 | 1 | female | 1 | 8 | 8 | Coma | Coma | 1 | null | under $11k | 55 | 33,577 | 21,423.25 | 25,377.0156 | 39 | white | 17.796875 | 30 | 0.233978 | 0.168976 | 10 | 1 | 0 | no | 0 | 0 | dnr after sadm | 6 | 53 | 5.5 | 78 | 10 | 39 | 124 | 3.699707 | 0.599976 | 1.399902 | 130 | 7.279297 | 225 | 29 | 2,125 | null | 1 | <2 mo. follow-up | 1 |
7,552 | 33.46997 | 0 | male | 0 | 4 | 490 | CHF | COPD/CHF/Cirrhosis | 1 | 12 | $11-$25k | 0 | 3,483 | 2,353.5195 | 2,468.35938 | 11 | white | 15.699219 | 6 | 0.948975 | 0.912964 | 1 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 4 | 124 | 12.5 | 116 | 24 | 38.59375 | 276.625 | 3 | 0.5 | 1.099854 | 143 | 7.429688 | 135 | 20 | 1,288 | 0 | 0 | no(M2 and SIP pres) | 0 |
7,553 | 39.62198 | 0 | male | 0 | 47 | 489 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | under $11k | 0 | 99,971 | 62,746.625 | 70,309.1875 | 33 | black | 22.699219 | 46 | 0.888916 | 0.848999 | 1 | 0 | 0 | no | 0.75 | 0.7 | no dnr | 47 | 99 | 7.299805 | 120 | 24 | 36.59375 | 212.5 | null | null | 2.299805 | 139 | 7.389648 | 90 | 10 | 1,400 | null | 6 | adl>=4 (>=5 if sur) | 6 |
7,554 | 74.39294 | 1 | female | 0 | 11 | 16 | Lung Cancer | Cancer | 1 | 15 | under $11k | 0 | 13,282 | 8,855.1875 | 11,715.9297 | 17.5 | white | 28.5 | 23 | 0.380981 | 0.091995 | 1 | 0 | 0 | metastatic | 0.6 | 0.2 | dnr after sadm | 1 | 73 | 7.599609 | 64 | 24 | 35.59375 | 442.8125 | 2.799805 | 1.899902 | 1.099854 | 136 | 7.509766 | 73 | 26 | 2,375 | 0 | 2 | <2 mo. follow-up | 2 |
7,555 | 60.51199 | 0 | female | 0 | 6 | 488 | CHF | COPD/CHF/Cirrhosis | 0 | 8 | $11-$25k | 0 | 5,472 | 3,706.3887 | 3,897.24805 | 12 | black | 13.599609 | 14 | 0.922974 | 0.869995 | 1 | 0 | 0 | no | 0.8 | 0.6 | no dnr | 6 | 63 | 5.799805 | 152 | 16 | 39.09375 | null | 2.599609 | 3.899902 | 0.799927 | 127 | null | 94 | 6 | 1,450 | 0 | null | no(M2 and SIP pres) | 0.494751 |
7,556 | 68.12 | 1 | male | 1 | 25 | 25 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | 18 | under $11k | 9 | 25,188 | 17,244.2031 | 19,472.0156 | 7.5 | white | 33.5 | 59 | 0.359985 | 0.167999 | 1 | 0 | 0 | no | 0.9 | 0.7 | dnr after sadm | 17 | 108 | 6.899414 | 96 | 22 | 35.39844 | null | 2.599609 | 4.799805 | 0.5 | 126 | null | 94 | 1 | null | 0 | null | <2 mo. follow-up | 0.494751 |
7,557 | 60.04398 | 1 | male | 0 | 6 | 169 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 14 | under $11k | 0 | 15,198 | 10,064.9766 | 10,894.9453 | 41 | white | 23.898438 | 52 | 0.824951 | 0.765991 | 1 | 1 | 0 | no | 0.9 | 0.9 | no dnr | 6 | 136 | 11.798828 | 133 | 36 | 36.5 | 125 | 2.099609 | 0.399963 | 3.799805 | 139 | 7.329102 | 120 | 72 | 1,237 | 0 | 0 | no(M2 and SIP pres) | 0 |
7,558 | 70.56799 | 0 | male | 0 | 9 | 481 | COPD | COPD/CHF/Cirrhosis | 4 | 9 | under $11k | 0 | 12,137 | 6,805.6562 | 7,839.60938 | 15 | white | 21.5 | 27 | 0.776978 | 0.643921 | 1 | 0 | 0 | yes | 0.9 | 0.8 | no dnr | 9 | 69 | 8.798828 | 80 | 20 | 36.79688 | null | 3.599609 | 1.199951 | 1.299805 | 143 | null | 65 | 33 | 850 | 1 | 0 | adl>=4 (>=5 if sur) | 0 |
7,559 | 50.543 | 1 | female | 0 | 21 | 39 | MOSF w/Malig | ARF/MOSF | 2 | 3 | $25-$50k | 9 | 50,746 | 34,318.1875 | 41,470.5 | 29.666656 | white | 32 | 41 | 0.385986 | 0.266968 | 9 | 0 | 0 | yes | 0.75 | 0.6 | no dnr | 21 | 66 | 6.299805 | 109 | 25 | 36.29688 | 202.21875 | 2.699707 | 1 | 1.099854 | 132 | 7.389648 | 126 | 33 | 1,115 | 7 | 7 | <2 mo. follow-up | 7 |
7,560 | 72.50696 | 1 | male | 0 | 6 | 119 | CHF | COPD/CHF/Cirrhosis | 1 | 0 | under $11k | 0 | 14,569 | 7,082.6367 | 8,828.42969 | 20 | white | 23.199219 | 28 | 0.770996 | 0.634888 | 3 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 6 | 116 | 14.099609 | 147 | 26 | 36.79688 | 328.5625 | 4 | 0.699951 | 1 | 135 | 7.469727 | 109 | 16 | 1,750 | null | null | null | 3.085449 |
7,561 | 66.672 | 1 | male | 0 | 22 | 183 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 14 | $11-$25k | 0 | 29,171 | 18,045.1094 | 22,454.75 | 19.333328 | black | 19.5 | 29 | 0.85791 | 0.80896 | 1 | 1 | 0 | no | 0.9 | 0.8 | no dnr | 22 | 77 | 6.299805 | 77 | 20 | 36.19531 | 404.75 | 4.299805 | 1.099854 | 2.099609 | 134 | 7.399414 | 100 | 16 | null | 0 | 0 | no(M2 and SIP pres) | 0 |
7,562 | 61.13898 | 1 | male | 0 | 8 | 283 | Coma | Coma | 0 | null | under $11k | 44 | 7,577 | 5,176.9258 | 5,870.35938 | 11 | black | 24.097656 | 30 | 0.529907 | 0.459961 | 1 | 0 | 0 | no | 0.6 | 0.5 | no dnr | 8 | 60 | 18 | 74 | 10 | 36.39844 | 63 | 1.299805 | 2.599609 | 2.799805 | 146 | 7.319336 | 97 | 56 | 992 | null | 7 | adl>=4 (>=5 if sur) | 7 |
7,563 | 69.36896 | 0 | female | 0 | 13 | 484 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 9 | 14,009 | 9,544.2656 | 10,667.0859 | 17.5 | white | 27.398438 | 43 | 0.525879 | 0.325989 | 1 | 0 | 0 | no | 0.5 | 0.4 | dnr after sadm | 1 | 109 | 14.699219 | 125 | 22 | 36.5 | 353.3125 | 1.799805 | 0.5 | 1.5 | 132 | 7.369141 | 107 | 12 | 3,120 | 6 | 4 | null | 4 |
7,564 | 72.96594 | 1 | male | 0 | 18 | 49 | Colon Cancer | Cancer | 1 | 19 | $25-$50k | 0 | 26,584 | 19,455.9688 | 28,796.6562 | 23 | white | 33.5 | 49 | 0.429993 | 0.122986 | 1 | 0 | 0 | metastatic | 0.75 | 0.6 | dnr after sadm | 17 | 137 | 10 | 122 | 12 | 38.09375 | 240 | 1.899902 | 1.199951 | 0.899902 | 149 | 7.539062 | 194 | 27 | 1,232 | 0 | 0 | <2 mo. follow-up | 0 |
7,565 | 68.54797 | 0 | male | 0 | 95 | 481 | COPD | COPD/CHF/Cirrhosis | 4 | null | null | 37 | 197,417 | 126,041.625 | 151,807.5 | 55.25 | white | 38.898438 | 42 | 0.228973 | 0.075989 | 3 | 0 | 0 | no | null | null | no dnr | 95 | 61 | 104 | 176 | 26 | 39.29688 | 105 | 2.199707 | 2.399902 | 2.899902 | 141 | 7.319336 | 376 | 70 | 1,113 | null | null | Coma or Intub | 5.333008 |
7,566 | 79.12396 | 1 | female | 1 | 3 | 3 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | null | under $11k | 100 | 18,622 | 11,870.8281 | 13,468.7656 | null | black | 82.390625 | 113 | 0 | 0 | 5 | 1 | 0 | no | null | null | no dnr | 3 | 66 | 6.699219 | 50 | 30 | 35 | 404.0625 | 2.099609 | 0.599976 | 2.699707 | 136 | 7.279297 | 81 | 108 | 337 | null | null | <2 mo. follow-up | 2.645996 |
7,567 | 62.883 | 0 | female | 0 | 4 | 480 | COPD | COPD/CHF/Cirrhosis | 2 | null | under $11k | 0 | 3,748 | 2,488.6074 | 2,575.55859 | 7 | white | 15 | 14 | 0.91394 | 0.85498 | 1 | 0 | 0 | no | 0.5 | 0.4 | no dnr | 4 | 71 | 21.699219 | 109 | 26 | 38.29688 | 134.6875 | 2 | 0.799927 | 1.599854 | 134 | 7.429688 | 100 | 30 | 5,752 | 0 | null | SIP>=30 | 0.494751 |
7,568 | 78.31897 | 0 | female | 0 | 9 | 480 | COPD | COPD/CHF/Cirrhosis | 2 | null | under $11k | 0 | 12,338 | 7,648.0586 | 8,438.74219 | 20.5 | white | 21.398438 | 55 | 0.771973 | 0.636963 | 1 | 0 | 0 | no | 0.5 | 0.25 | dnr after sadm | 1 | 60 | 9.5 | 118 | 40 | 36.19531 | 285.6875 | 2.399902 | 2.199707 | 1.399902 | 130 | 7.379883 | 124 | 50 | 966 | null | 5 | adl>=4 (>=5 if sur) | 5 |
7,569 | 69.21295 | 1 | male | 0 | 3 | 118 | Lung Cancer | Cancer | 2 | 16 | $11-$25k | 0 | 3,566 | 2,432.3281 | 2,913.5293 | null | white | 21.699219 | 9 | 0.589966 | 0.270996 | 1 | 0 | 0 | metastatic | null | null | no dnr | 3 | 99 | 6 | 72 | 20 | 35.79688 | null | 3.199707 | 1.399902 | 1 | 138 | null | 331 | 13 | 2,600 | null | null | no(M2 and SIP pres) | 2.800293 |
7,570 | 58.76797 | 0 | male | 0 | 5 | 479 | Coma | Coma | 1 | 12 | $11-$25k | 55 | 14,700 | 8,925.7891 | 10,656.9844 | 29 | black | 20 | 34 | 0.606934 | 0.542969 | 1 | 1 | 0 | no | 0.4 | 0.4 | no dnr | 5 | 109 | 4.699219 | 64 | 20 | 36.09375 | null | 3.899902 | 0.699951 | 1.599854 | 140 | null | 153 | 22 | 1,700 | null | 0 | adl>=4 (>=5 if sur) | 0 |
7,571 | 38.11899 | 0 | female | 0 | 16 | 479 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 8 | under $11k | 9 | 47,093 | 28,861.0938 | 33,175.9375 | 30.333328 | white | 27.5 | 25 | 0.782959 | 0.711914 | 1 | 0 | 0 | yes | 0.9 | 0.9 | no dnr | 16 | 133 | 19.5 | 133 | 36 | 36.19531 | 223.0625 | 3.099609 | 0.899902 | 0.5 | 141 | 7.389648 | 161 | 9 | 1,425 | null | 0 | no(M2 and SIP pres) | 0 |
7,572 | 66.91296 | 1 | female | 1 | 26 | 26 | COPD | COPD/CHF/Cirrhosis | 3 | 12 | $11-$25k | 0 | 86,018 | 52,848.6875 | 61,411.9688 | 32.25 | white | 23.5 | 32 | 0.790894 | 0.66394 | 3 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 26 | 103 | 7.599609 | 80 | 24 | 35.89844 | 220 | 3.699707 | 0.299988 | 1 | 132 | 7.399414 | 139 | 16 | 1,850 | null | 0 | <2 mo. follow-up | 0 |
7,573 | 36.80798 | 0 | male | 0 | 9 | 476 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 12 | under $11k | 41 | 29,838 | 18,833.5156 | 21,812.75 | 35 | white | 32.398438 | 47 | 0.642944 | 0.542969 | 1 | 0 | 0 | no | 0.5 | 0.4 | no dnr | 9 | 69 | 15.5 | 67 | 10 | 35.69531 | 502 | 1.899902 | 1.799805 | 0.699951 | 136 | 7.419922 | 182 | 13 | 1,915 | null | 0 | no(M2 and SIP pres) | 0 |
7,574 | 76.57996 | 1 | male | 1 | 7 | 7 | Coma | Coma | 2 | 10 | $11-$25k | 61 | 16,563 | 10,596.4062 | 12,530.3438 | 32 | white | 24 | 41 | 0.28595 | 0.215973 | 1 | 1 | 0 | no | 0.3 | 0.2 | dnr after sadm | 3 | 69 | 11.599609 | 171 | 55 | 38.79688 | 142.5 | 2.799805 | 0.899902 | 1.399902 | 144 | 7.519531 | 107 | 17 | 1,092 | null | 0 | <2 mo. follow-up | 0 |
7,575 | 71.24396 | 0 | female | 0 | 35 | 474 | MOSF w/Malig | ARF/MOSF | 4 | 12 | under $11k | 0 | 108,652 | 71,450.875 | 79,561.625 | 23.25 | white | 22.796875 | 37 | 0.536987 | 0.422974 | 31 | 0 | 0 | metastatic | 0 | 0 | dnr after sadm | 2 | 126 | 6.399414 | 134 | 32 | 38 | 106.65625 | 2.199707 | 11.199219 | 0.899902 | 128 | 7.549805 | 134 | 5 | 575 | null | 2 | null | 2 |
7,576 | 67.25 | 0 | male | 0 | 3 | 473 | CHF | COPD/CHF/Cirrhosis | 4 | 14 | null | 0 | 2,763 | 1,765.1641 | 2,354.55859 | null | white | 21.5 | 28 | 0.838989 | 0.735962 | 1 | 0 | 0 | no | null | null | no dnr | 3 | 69 | 24 | 126 | 22 | 36.69531 | 220 | null | 0.599976 | 1.199951 | 137 | 7.369141 | 160 | 40 | 1,560 | null | null | no(M2 and SIP pres) | 2.708984 |
7,577 | 52.698 | 0 | female | 0 | 9 | 472 | COPD | COPD/CHF/Cirrhosis | 2 | 9 | under $11k | 0 | 21,141 | 12,759.8672 | 14,685.0781 | 33.5 | white | 27.597656 | 39 | 0.837891 | 0.734985 | 1 | 0 | 0 | no | null | null | no dnr | 9 | 127 | 16.296875 | 107 | 24 | 38.19531 | 288 | 2.599609 | 1 | 2.099609 | 140 | 7.329102 | 81 | 63 | 3,993 | null | 3 | no(M2 and SIP pres) | 3 |
7,578 | 52.00497 | 1 | male | 1 | 7 | 7 | Coma | Coma | 1 | 8 | $11-$25k | 44 | 14,741 | 9,165.6875 | 10,467.9062 | 17 | white | 16.699219 | 29 | 0.763916 | 0.719971 | 1 | 0 | 0 | no | 0.4 | 0.35 | dnr after sadm | 4 | 0 | 11 | 150 | 31 | 38.79688 | 297.5 | 1.799805 | 4.199219 | 3.699707 | 125 | 7.379883 | 42 | 66 | 5,930 | null | 0 | <2 mo. follow-up | 0 |
7,579 | 59.89297 | 0 | female | 0 | 4 | 468 | CHF | COPD/CHF/Cirrhosis | 4 | null | null | 0 | 3,672 | 2,393.9316 | 2,511.20898 | 6 | black | 14.5 | 17 | 0.917969 | 0.861938 | 1 | 1 | 0 | no | 0.95 | 0.95 | no dnr | 4 | 135 | 14.898438 | 105 | 5 | 38.39844 | 356.625 | null | null | 0.699951 | 131 | 7.479492 | 144 | 13 | 1,618 | null | null | null | 3.274902 |
7,580 | 57.98499 | 1 | female | 0 | 5 | 415 | COPD | COPD/CHF/Cirrhosis | 6 | 12 | $11-$25k | 0 | 7,687 | 4,499.8242 | 5,196.07812 | 22 | white | 16.898438 | 32 | 0.892944 | 0.820923 | 1 | 1 | 0 | yes | 0.9 | 0.6 | no dnr | 5 | 120 | 3.799805 | 77 | 20 | 37 | null | 3.299805 | 1 | 1 | 134 | null | 176 | 10 | null | 0 | 1 | null | 1 |
7,581 | 72.31494 | 0 | female | 0 | 8 | 468 | CHF | COPD/CHF/Cirrhosis | 3 | 10 | $11-$25k | 0 | 17,686 | 10,106.5 | 12,971.2031 | 14.5 | white | 12.599609 | 18 | 0.908936 | 0.845947 | 1 | 1 | 0 | no | 0.99 | 0.9 | no dnr | 8 | 64 | 4.5 | 111 | 8 | 38.19531 | 523.75 | 2.599609 | 0.399963 | 0.599976 | 137 | 7.429688 | 83 | 10 | 4,105 | 0 | 0 | no(M2 and SIP pres) | 0 |
7,582 | 54.32397 | 0 | male | 0 | 9 | 466 | COPD | COPD/CHF/Cirrhosis | 5 | 12 | under $11k | 0 | 12,159 | 7,667.8555 | 8,439.94531 | 15.5 | black | 20.296875 | 41 | 0.901978 | 0.835938 | 1 | 0 | 0 | no | 0.8 | 0.75 | dnr after sadm | 6 | 110 | 3.5 | 122 | 28 | 37.89844 | null | 2.699707 | 0.399963 | 1.5 | 133 | null | 112 | 30 | 1,275 | 1 | 4 | SIP>=30 | 4 |
7,583 | 60.30698 | 1 | male | 1 | 14 | 14 | MOSF w/Malig | ARF/MOSF | 4 | 12 | under $11k | 26 | 63,465 | 39,629.4688 | 49,235.625 | 38.333313 | white | 33.796875 | 65 | 0.232971 | 0.132996 | 8 | 0 | 0 | yes | 0.7 | 0.7 | dnr after sadm | 7 | 83 | 0.699951 | 101 | 20 | 35.79688 | null | 3.599609 | 0.599976 | 1.299805 | 133 | null | 108 | 18 | null | 6 | 2 | <2 mo. follow-up | 2 |
7,584 | 63.258 | 1 | male | 1 | 51 | 51 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | under $11k | 37 | 128,478 | 79,063.25 | 91,306.6875 | 37.75 | white | 22 | 36 | 0.545898 | 0.432983 | 6 | 1 | 0 | metastatic | 0.5 | 0.4 | dnr after sadm | 51 | 140 | 15.099609 | 150 | 25 | 38.69531 | 314 | null | null | 1.199951 | 149 | 7.429688 | 163 | 31 | 3,680 | null | 3 | <2 mo. follow-up | 3 |
7,585 | 65.01599 | 1 | male | 1 | 10 | 10 | MOSF w/Malig | ARF/MOSF | 1 | 10 | under $11k | 9 | 31,724 | 20,273.4844 | 25,110.5781 | 40 | white | 32.5 | 57 | 0.440979 | 0.32196 | 1 | 0 | 0 | yes | 0.2 | 0 | dnr after sadm | 7 | 69 | 0.799927 | 146 | 24 | 36.39844 | null | 2 | 1 | 0.699951 | 131 | null | 117 | 11 | 5,050 | null | 1 | <2 mo. follow-up | 1 |
7,586 | 32.12299 | 0 | female | 0 | 6 | 463 | COPD | COPD/CHF/Cirrhosis | 3 | 12 | under $11k | 0 | 6,625 | 4,011.2188 | 4,399.70703 | 12 | white | 22.398438 | 28 | 0.944946 | 0.905884 | 1 | 0 | 0 | no | 1 | 0.75 | no dnr | 6 | 90 | 10.699219 | 76 | 20 | 35.89844 | null | 2.299805 | 0.5 | 1 | 131 | null | 127 | 17 | null | 0 | null | null | 0.494751 |
7,587 | 73.98999 | 0 | female | 0 | 5 | 463 | Colon Cancer | Cancer | 1 | 12 | $11-$25k | 9 | 4,497 | 3,107.4102 | 4,095.87891 | 13 | white | 27.898438 | 20 | 0.53894 | 0.21698 | 1 | 0 | 0 | metastatic | 0.5 | 0.2 | dnr after sadm | 3 | 120 | 17.597656 | 71 | 26 | 38.69531 | 190 | 2.699707 | 0.799927 | 5.599609 | 144 | 7.319336 | 99 | 65 | 1,517 | 1 | 1 | no(M2 and SIP pres) | 1 |
7,588 | 75.98395 | 0 | male | 0 | 21 | 463 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 8 | under $11k | 44 | 40,937 | 27,263.9688 | 32,782.125 | 30 | black | 29.796875 | 58 | 0.387939 | 0.268982 | 4 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 21 | 118 | 9.599609 | 55 | 10 | 37.69531 | 363.3125 | null | null | 0.5 | 134 | 7.419922 | 120 | 11 | 2,285 | null | 7 | adl>=4 (>=5 if sur) | 7 |
7,589 | 64.26599 | 0 | female | 0 | 5 | 461 | COPD | COPD/CHF/Cirrhosis | 2 | 6 | under $11k | 0 | 10,697 | 6,611.6211 | 8,725.60938 | 15 | white | 23.097656 | 24 | 0.833984 | 0.727905 | 1 | 1 | 0 | no | 1 | 1 | no dnr | 5 | 76 | 9.798828 | 130 | 20 | 36.5 | 200 | 3.299805 | 1.099854 | 1 | 137 | 7.449219 | 102 | 18 | null | 1 | 1 | no(M2 and SIP pres) | 1 |
7,590 | 67.95898 | 0 | male | 0 | 3 | 461 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | $11-$25k | 0 | 2,667 | 1,682.0225 | 1,844.41992 | null | white | 14.898438 | 10 | 0.898926 | 0.830933 | 1 | 0 | 0 | no | 1 | 0.9 | no dnr | 3 | 90 | 10.199219 | 116 | 20 | 36.29688 | null | 3.599609 | 0.399963 | 1.099854 | 136 | null | 106 | 17 | 1,700 | 0 | 0 | no(M2 and SIP pres) | 0 |
7,591 | 57.383 | 0 | male | 0 | 3 | 461 | CHF | COPD/CHF/Cirrhosis | 1 | 15 | under $11k | 0 | 9,595 | 5,629.1094 | 7,239.08984 | 14 | white | 14.798828 | 23 | 0.920898 | 0.865967 | 1 | 0 | 0 | no | 0.95 | 0.9 | no dnr | 3 | 131 | 5.899414 | 53 | 38 | 38.59375 | 158 | 2.599609 | 7 | 0.799927 | 137 | 7.399414 | 176 | 28 | 1,868 | 0 | 0 | SIP>=30 | 0 |
7,592 | 65.51398 | 0 | male | 0 | 15 | 460 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 12 | null | 0 | 89,647 | 58,617.6562 | 66,263.625 | 26.666656 | white | 36.398438 | 64 | 0.215973 | 0.068985 | 37 | 0 | 0 | no | 0.3 | 0.3 | no dnr | 15 | 110 | 16.398438 | 71 | 22 | 36.19531 | 172 | null | 0.5 | 0.899902 | 138 | 7.269531 | 97 | 13 | 2,190 | null | 0 | no(M2 and SIP pres) | 0 |
7,593 | 76.72296 | 1 | female | 0 | 6 | 245 | MOSF w/Malig | ARF/MOSF | 1 | 8 | under $11k | 0 | 8,117 | 5,389.4609 | 6,440.42969 | 20 | black | 26.398438 | 26 | 0.552979 | 0.438965 | 1 | 0 | 0 | metastatic | 0.8 | 0.5 | no dnr | 6 | 99 | 8.298828 | 106 | 16 | 35.5 | 500 | 3.439941 | 5.299805 | 1.399902 | 130 | 7.509766 | 51 | 42 | null | 0 | 0 | no(M2 and SIP pres) | 0 |
7,594 | 60.76398 | 1 | female | 0 | 88 | 89 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 1 | under $11k | 9 | 192,117 | 117,801.75 | 129,911.562 | 42.5 | white | 21.5 | 22 | 0.832886 | 0.776978 | 1 | 0 | 0 | no | 0.7 | 0.75 | dnr after sadm | 14 | 101 | 10.099609 | 72 | 24 | 36.59375 | null | 4.299805 | 0.599976 | 1.5 | 138 | null | 107 | 17 | 1,925 | null | 0 | adl>=4 (>=5 if sur) | 0 |
7,595 | 75.92297 | 1 | male | 1 | 47 | 47 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 11 | null | 0 | 210,541 | 138,336.5 | 174,062 | 49 | white | 25.398438 | 66 | 0.648926 | 0.549927 | 38 | 0 | 0 | no | 0.1 | 0.05 | dnr after sadm | 45 | 128 | 16 | 78 | 32 | 36.59375 | 228.5625 | 3 | 1 | 1.299805 | 114 | 7.379883 | 188 | 19 | 4,805 | null | 0 | <2 mo. follow-up | 0 |
7,596 | 24.69299 | 0 | male | 0 | 24 | 455 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 10 | under $11k | 0 | 155,743 | 101,314.812 | 127,360.25 | 28.333328 | white | 22.5 | 35 | 0.848999 | 0.795898 | 68 | 0 | 0 | yes | 0.9 | 0.9 | no dnr | 24 | 126 | 3 | 77 | 28 | 38 | 267.8125 | 2.599609 | 5 | 0.899902 | 136 | 7.439453 | 85 | 13 | 2,975 | 0 | 0 | null | 0 |
7,597 | 57.24799 | 0 | female | 0 | 5 | 455 | Colon Cancer | Cancer | 1 | 13 | null | 0 | 6,553 | 4,324.3398 | 4,882.61719 | 7 | white | 12.099609 | 3 | 0.882935 | 0.734985 | 1 | 0 | 0 | metastatic | 1 | 0.9 | no dnr | 5 | 99 | 0.699951 | 120 | 40 | 38.29688 | null | 2.099609 | 1.199951 | 0.899902 | 137 | null | 164 | 7 | 1,600 | 0 | null | no(M2 and SIP pres) | 0.494751 |
7,598 | 72.19995 | 1 | male | 1 | 9 | 9 | MOSF w/Malig | ARF/MOSF | 2 | 16 | under $11k | 9 | 44,016 | 30,163.4062 | 38,612.875 | 27.5 | white | 25.097656 | 31 | 0.517944 | 0.40094 | 20 | 0 | 1 | yes | 0.5 | 0.5 | dnr before sadm | -9 | 117 | 4.199219 | 60 | 22 | 36.29688 | 196 | 2.099609 | 0.199982 | 2.299805 | 138 | 7.319336 | 117 | 62 | 1,150 | null | 7 | <2 mo. follow-up | 7 |
7,599 | 40.06598 | 0 | male | 0 | 48 | 453 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | under $11k | 0 | 159,555 | 98,485.4375 | 113,089.188 | 43 | white | 29.5 | 62 | 0.812988 | 0.750977 | 1 | 1 | 0 | no | 0.8 | 0.8 | no dnr | 48 | 71 | 17.898438 | 84 | 20 | 36.89844 | null | 2.399902 | 20.398438 | 1 | 127 | null | 70 | 13 | null | null | 7 | SIP>=30 | 7 |
7,600 | 66.26398 | 1 | male | 0 | 5 | 114 | COPD | COPD/CHF/Cirrhosis | 3 | 8 | under $11k | 0 | 13,492 | 8,294.0156 | 9,444.0625 | 13 | black | 17.597656 | 25 | 0.785889 | 0.656982 | 4 | 1 | 0 | metastatic | 0.5 | 0.25 | no dnr | 5 | 69 | 10.298828 | 61 | 10 | 37.89844 | 190 | 3.099609 | 1.399902 | 1.099854 | 143 | 7.389648 | 118 | 11 | 4,375 | 0 | 0 | no(M2 and SIP pres) | 0 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.